Muscle recovery and DOMS reduction
Multiple RCTs demonstrate tart cherry significantly reduces delayed onset muscle soreness (DOMS), strength loss, and inflammatory markers after eccentric exercise and endurance events. Studies show 20–25% reduction in post-exercise strength loss and accelerated return to baseline performance.
Sleep quality improvement
As one of the richest natural sources of melatonin among plant foods, tart cherry significantly improves sleep duration and quality. Clinical trials show increased sleep time (+34–39 minutes), improved sleep efficiency, and reduced insomnia symptoms — effects from both melatonin content and anti-inflammatory activity reducing sleep-disrupting pain.
Anti-inflammatory and antioxidant activity
Tart cherry anthocyanins inhibit COX-1 and COX-2 enzymes (NSAID-like mechanism), reduce IL-6, CRP, and uric acid, and provide potent antioxidant protection post-exercise. The anti-inflammatory potency per serving rivals ibuprofen in some studies.
Uric acid reduction and gout prevention
Tart cherry consumption significantly reduces serum uric acid levels and the frequency of acute gout attacks. Anthocyanins inhibit xanthine oxidase (the enzyme that produces uric acid) and promote renal uric acid excretion — a dual mechanism for hyperuricemia management.
Endurance performance support
Marathon and cycling studies show tart cherry supplementation (5–7 days pre-race through recovery) reduces post-race muscle damage biomarkers, accelerates strength recovery, and improves time to return to peak performance — particularly valuable for athletes competing in back-to-back events.
COX-1/COX-2 inhibition and prostaglandin reduction
Anthocyanins from tart cherry inhibit cyclooxygenase enzymes that produce prostaglandins — the primary mediators of exercise-induced inflammation and pain. This NSAID-like mechanism reduces post-exercise soreness without the GI side effects of pharmaceutical COX inhibitors.
Melatonin-mediated sleep promotion
Tart cherries contain 13.5 ng/g melatonin — among the highest of any plant food. Combined with tryptophan (melatonin precursor) and serotonin present in tart cherry, supplementation produces physiologically meaningful increases in urinary melatonin metabolites and improved sleep architecture.
Xanthine oxidase inhibition and urate lowering
Tart cherry anthocyanins inhibit xanthine oxidase, the enzyme that catalyzes the final two steps of uric acid biosynthesis from hypoxanthine and xanthine. This mechanism directly reduces uric acid production, complementing the renal urate excretion effects of cherry consumption.
RCT of tart cherry juice (240 mL twice daily) vs. placebo in 20 marathon runners for 5 days before and 2 days after a marathon.
20 trained marathon runners. 7-day supplementation spanning race day.
Tart cherry group showed 20% less post-race strength loss, significantly lower inflammatory markers (IL-6, CRP), and faster recovery of isometric strength. Supports tart cherry as effective endurance recovery aid.
RCT of tart cherry juice (240 mL twice daily) vs. placebo in 20 older adults with insomnia for 2 weeks.
20 older adults with insomnia. 2-week intervention.
Tart cherry juice significantly increased total sleep time (+39 min), sleep efficiency (+6%), and reduced insomnia severity vs. placebo. Urinary melatonin metabolites significantly increased. Well-tolerated.
Prospective study examining tart cherry consumption and gout attack frequency in 633 gout patients over 2 years.
633 gout patients. 2-year prospective follow-up.
Tart cherry consumption was associated with 35% lower risk of gout attacks vs. no consumption. Daily consumption reduced risk by 45%. Effect significantly enhanced by concurrent allopurinol use.